{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:18:57Z","timestamp":1791674337360,"version":"4.3.4"},"reference-count":20,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2025,7,8]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to compare the incidence of severe infections between mycophenolate mofetil (MMF) and other immunosuppressants in patients with systemic lupus erythematosus (SLE) on maintenance therapy using data from the Lupus Registry of Nationwide Institutions in Japan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This study employed a prospective cohort design, including patients with SLE undergoing maintenance therapy. Exposure was defined as MMF treatment, and the control group included individuals who received other immunosuppressants (non-MMF) treatments. Severe infections requiring hospitalisation were the primary outcomes, whereas secondary outcomes included all-cause hospitalisation, changes in prednisolone dosage, disease activity and organ damage. Statistical analyses employed marginal structural models with stabilised inverse probability of treatment weighting to adjust for confounders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analysis included 1004 patients; the incidence of severe infections was 6.5% in the MMF group and 7.5% in the non-MMF group, with no significant difference (OR 0.69, 95% CI 0.34 to 1.39). Similarly, all-cause hospitalisation rates were comparable between the groups (OR 0.72, 95%\u2009CI 0.47 to 1.09). Prednisolone dosage was significantly reduced in the MMF group (\u22120.66\u2009mg\/day, 95%\u2009CI \u22121.09 to \u22120.23). The organ damage score was modestly reduced in the MMF group (\u22120.19 points, 95%\u2009CI \u22120.37 to \u22120.01), whereas the change of disease activity score was comparable between the groups (\u22120.10 points, 95%\u2009CI \u22120.74 to 0.55).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>MMF does not significantly increase the risk of severe infections compared with other immunosuppressants in SLE maintenance therapy. MMF may contribute to reducing the dose of prednisolone.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2025-005558","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:10:20Z","timestamp":1753243820000},"page":"e005558","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Safety of mycophenolate mofetil in systemic lupus erythematosus maintenance therapy: insights from the LUNA registry in a nationwide prospective cohort study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7348-5692","authenticated-orcid":false,"given":"Naoki","family":"Matsuoka","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-3962","authenticated-orcid":false,"given":"Nobuyuki","family":"Yajima","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Showa Medical university, Tokyo, Japan"},{"name":"Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine and Public Health, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Research Administration Center, Showa Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8110-8261","authenticated-orcid":false,"given":"Shuzo","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2842-6159","authenticated-orcid":false,"given":"Yuya","family":"Sumichika","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Saito","sequence":"additional","affiliation":[{"name":"Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Temmoku","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumpei","family":"Fukita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Showa Medical university, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-0818","authenticated-orcid":false,"given":"Ken-ei","family":"Sada","sequence":"additional","affiliation":[{"name":"Kochi Medical School, Kochi, Japan"},{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8794-7106","authenticated-orcid":false,"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Shimane University Faculty of Medicine, Shimane, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[{"name":"Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Kanagawa, Japan"},{"name":"Clinical Laboratory Department, Yokohama City University Hospital, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Diseases, Yokohama City University Medical Center, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajiyama","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-1121","authenticated-orcid":false,"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Yokohama Rosai Hospital, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-8352","authenticated-orcid":false,"given":"Takashi","family":"Kida","sequence":"additional","affiliation":[{"name":"Inflammation and Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshia","family":"Miyawaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Kyosai Hospital, Tokyo, Japan"},{"name":"Department of Rheumatology, Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Onishi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kakogawa Central City Hospital, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"2025100518351023000_11.3.e005558.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.39"},{"key":"2025100518351023000_11.3.e005558.2","first-page":"s2","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14 Suppl 1","author":"Allison","year":"2005","journal-title":"Lupus (Los Angel)"},{"key":"2025100518351023000_11.3.e005558.3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008101028"},{"key":"2025100518351023000_11.3.e005558.4","unstructured":"New ACR guideline summary provides guidance to screen, treat, and manage lupus nephritis. 2024 Available: https:\/\/rheumatology.org\/press-releases\/new-acr-guideline-summary-provides-guidance-to-screen-treat-and-manage-lupus-nephritis"},{"key":"2025100518351023000_11.3.e005558.5","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762"},{"key":"2025100518351023000_11.3.e005558.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.09.002"},{"key":"2025100518351023000_11.3.e005558.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.11.001"},{"key":"2025100518351023000_11.3.e005558.8","first-page":"309","article-title":"Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual","volume":"16","author":"Nossent","year":"2007","journal-title":"Lupus (Los Angel)"},{"key":"2025100518351023000_11.3.e005558.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381016"},{"key":"2025100518351023000_11.3.e005558.10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/rheumatology\/kem180","article-title":"Causes and predictors of death in South Africans with systemic lupus erythematosus","volume":"46","author":"Wadee","year":"2007","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025100518351023000_11.3.e005558.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014460"},{"key":"2025100518351023000_11.3.e005558.12","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2025100518351023000_11.3.e005558.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.131995"},{"key":"2025100518351023000_11.3.e005558.14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/art.39849","article-title":"Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications","volume":"69","author":"Feldman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025100518351023000_11.3.e005558.15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11020343","article-title":"Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses","volume":"11","author":"Shin","year":"2022","journal-title":"J Clin Med"},{"key":"2025100518351023000_11.3.e005558.16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/rheumatology\/keh012","article-title":"Lupus nephritis: treatment with mycophenolate mofetil","volume":"43","author":"Kapitsinou","year":"2004","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025100518351023000_11.3.e005558.17","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/41.8.876","article-title":"Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents","volume":"41","author":"Karim","year":"2002","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025100518351023000_11.3.e005558.18","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150779"},{"key":"2025100518351023000_11.3.e005558.19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.32131","article-title":"Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial","volume":"7","author":"You","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025100518351023000_11.3.e005558.20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/rheumatology\/kep346","article-title":"Influence of race\/ethnicity on response to lupus nephritis treatment: the ALMS study","volume":"49","author":"Isenberg","year":"2010","journal-title":"Rheumatology (Sunnyvale)"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2025-005558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T01:35:22Z","timestamp":1759714522000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2025-005558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,7,22]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/rmdopen-2025-005558"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2025-005558","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}